 |
|
Genome in Germany
Rebecca Voelker
JAMA. 1999;282:123.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Recognizing genome research as a key technology for the next century, the Deutsch Forschungsgemeinschaft (DFG) has called on public and private sector scientists to create a national genome initiative in Germany.
A recent statement from the DFG, which is Germany's central public funding organization for academic research, recommended that funding for genome research be increased by 1 billion German marks over the next 5 years. Furthermore, the statement recommended that 40% of funding be devoted to research on the human genome and model organisms, 20% to plant genome research, and another 20% toward studying microorganism genomes. Bioinformatics and other related technologies should capture the remainder, according to the statement.
The DFG noted that growth of biotechnology companies in Germany is under way. The agency cited a 1998 report that indicated 465 such companies in Germany employ an estimated 10,000 people. In comparison, only 75 biotechnology companies were operating . . . [Full Text of this Article]
|
